Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5209038
Max Phase: Preclinical
Molecular Formula: C38H61F3N10O8
Molecular Weight: 728.94
Associated Items:
ID: ALA5209038
Max Phase: Preclinical
Molecular Formula: C38H61F3N10O8
Molecular Weight: 728.94
Associated Items:
Canonical SMILES: N=C(N)N[C@@H]1CCOCNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)Cc2cccc(c2)CNC(=O)[C@@H](CC2CCCCC2)NC1=O.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C36H60N10O6.C2HF3O2/c37-16-6-4-13-27-32(48)42-23-52-18-15-29(46-36(39)40)35(51)45-30(20-24-9-2-1-3-10-24)33(49)41-22-26-12-8-11-25(19-26)21-31(47)43-28(34(50)44-27)14-5-7-17-38;3-2(4,5)1(6)7/h8,11-12,19,24,27-30H,1-7,9-10,13-18,20-23,37-38H2,(H,41,49)(H,42,48)(H,43,47)(H,44,50)(H,45,51)(H4,39,40,46);(H,6,7)/t27-,28-,29+,30+;/m0./s1
Standard InChI Key: MDUSXMILNFIUNP-JDQRQYMYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 728.94 | Molecular Weight (Monoisotopic): 728.4697 | AlogP: -0.13 | #Rotatable Bonds: 11 |
Polar Surface Area: 268.67 | Molecular Species: BASE | HBA: 9 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 13 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.73 | CX Basic pKa: 11.00 | CX LogP: -1.36 | CX LogD: -8.47 |
Aromatic Rings: 1 | Heavy Atoms: 52 | QED Weighted: 0.08 | Np Likeness Score: 0.82 |
1. Huber S, Braun NJ, Schmacke LC, Quek JP, Murra R, Bender D, Hildt E, Luo D, Heine A, Steinmetzer T.. (2022) Structure-Based Optimization and Characterization of Macrocyclic Zika Virus NS2B-NS3 Protease Inhibitors., 65 (9.0): [PMID:35475620] [10.1021/acs.jmedchem.1c01860] |
Source(1):